{"id":992232,"date":"2026-08-07T10:11:17","date_gmt":"2026-08-07T14:11:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/"},"modified":"2026-08-07T10:11:17","modified_gmt":"2026-08-07T14:11:17","slug":"capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/","title":{"rendered":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Aug.  07, 2026  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Capricor Therapeutics, Inc. (NASDAQ: CAPR).<\/strong><\/p>\n<p>Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jYgp_o2RvgNeDrhQ4bJM8dDyTL6LKeQ4OSCIpppbyOqOgRF1JnfebJqDoqG4cSB8gJg9iE4hpkgBeZMtso5QwNPXbeDYXzxve09vvZuLe1fJmarXM8rEyAhP0zUbpJ-dKfsBBsTCXvoErHNdm4ODi655YxZcUqzDgDPpXv0ssPQehNu2xd0kjeNzgObuU-0wjx8e5OO3KVBdKISoX5dhKKe50x-rCm0A-sQiUcwLvZJKCq22B63TkduA7j5OphuX1ne_PYdKhO02wtalP-6D9z16x6PDQQN1MzbzsTJTYVYU3LGCYcBqyJGywzk3EIcwvRZCuYkWpi9bKCi-WJ9SJg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/capricor-therapeutics-inc-loss-submission-form-4\/?id=199126&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>December 17, 2025 to July 29, 2026<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for it&#8217;s lead product candidate, Deramiocel; (2) the FDA had not agreed to those changes before the Company resubmitted the Deramiocel BLA; (3) as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of Deramiocel; (4) as a result of the foregoing, there was a substantial risk to regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy; and (5) as a result of the foregoing, defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects were materially misleading and\/or lacked a reasonable basis.<\/p>\n<p>\n        <strong>DEADLINE: September 28, 2026<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jYgp_o2RvgNeDrhQ4bJM8dDyTL6LKeQ4OSCIpppbyOqOgRF1JnfebJqDoqG4cSB8gJg9iE4hpkgBeZMtso5QwNPXbeDYXzxve09vvZuLe1fJmarXM8rEyAhP0zUbpJ-dKfsBBsTCXvoErHNdm4ODi9yPRYz54EO3bDayVsweJZpIrfeUK1S_Sa8hEgqZGivIhY22tt5TIue5JO7pj7rgu3w1NytaWupwrsLzcBQ7qPoTrQaJRO56jrfmsAJ7H8GwRNrNP0soBjNMJTuxwtWOcLZg1fnl-Oxyedz4awyL7qbvMt1Rn8zwAIJ0KdNroOxfFbt41bvItJuc6EfhLvxTUw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/capricor-therapeutics-inc-loss-submission-form-4\/?id=199126&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of CAPR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 28, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=sl-0VqjlgzgL42yFnc6smvnd8RCDSz-gB23NdeT7xWGIwgCCQHOZWNaTA3FqV8Dufe8tUAZhglNMK7oLdd8Elu2i7bT9OU-xXhoYfMtoCprpy_j5rCTnaarmlqdUwD75\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDZmOWQ4ZDctNGE5OC00YjU1LWJjOGQtMDU3ZTcwZmVjYTcyLTEyNzA0NjctMjAyNi0wOC0wNy1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/capricor-therapeutics-inc-loss-submission-form-4\/?id=199126&amp;from=3 CLASS PERIOD: December 17, 2025 to July 29, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for it&#8217;s lead product candidate, Deramiocel; (2) the FDA had not agreed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-992232","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/capricor-therapeutics-inc-loss-submission-form-4\/?id=199126&amp;from=3 CLASS PERIOD: December 17, 2025 to July 29, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for it&#8217;s lead product candidate, Deramiocel; (2) the FDA had not agreed &hellip; Continue reading &quot;CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-07T14:11:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm\",\"datePublished\":\"2026-08-07T14:11:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/\"},\"wordCount\":442,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/\",\"name\":\"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\",\"datePublished\":\"2026-08-07T14:11:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk","og_description":"NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). Shareholders who purchased shares of CAPR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/capricor-therapeutics-inc-loss-submission-form-4\/?id=199126&amp;from=3 CLASS PERIOD: December 17, 2025 to July 29, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for it&#8217;s lead product candidate, Deramiocel; (2) the FDA had not agreed &hellip; Continue reading \"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-07T14:11:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm","datePublished":"2026-08-07T14:11:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/"},"wordCount":442,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/","name":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit - Contact The Gross Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=","datePublished":"2026-08-07T14:11:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwNTY3NyM3NzY0MjM4IzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/capr-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-capricor-therapeutics-inc-securities-lawsuit-contact-the-gross-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CAPR Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Capricor Therapeutics, Inc. Securities Lawsuit &#8211; Contact The Gross Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992232","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=992232"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/992232\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=992232"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=992232"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=992232"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}